Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects
PHASE3CompletedINTERVENTIONAL
Enrollment
34
Participants
Timeline
Start Date
January 31, 2012
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Conditions
Primary Sclerosing Cholangitis
Interventions
DRUG
Oral Vancomycin
Trial Locations (1)
94304
Stanford University Medical Center, Palo Alto
All Listed Sponsors
lead
Stanford University
OTHER
NCT01802073 - Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects | Biotech Hunter | Biotech Hunter